Clusters of matter and antimatter

In this talk I first give a short overview of antinuclei production in recent experiments at RHIC. Then I discuss the possibility of producing new types of nuclear systems by implanting an antibaryon into ordinary nuclei. The structure of nuclei containing one antiproton or antilambda is investigated within the framework of a relativistic mean-field model. Self-consistent calculations predict an enhanced binding and considerable compression in such systems as compared with normal nuclei. I present arguments that the life time of such nuclei with respect to the antibaryon annihilation might be long enough for their observation. Few experimental signatures are suggested. Possible formation of multi-quark-antiquark clusters is also discussed.Comment: 9 pages, 6 eps figures, invited talk at the VIII International Conference on Nucleus-Nucleus Collisions (Moscow, 17-21 June 2003

Local Impacts of Mercury Emissions from the Three Pennsylvania Coal Fired Power Plants.

The Clean Air Interstate Rule (CAIR) and the Clean Air Mercury Rule (CAMR) as proposed by the U.S. Environmental Protection Agency (EPA) when fully implemented will lead to reduction in mercury emissions from coal-fired power plants by 70 percent to fifteen tons per year by 2018. The EPA estimates that mercury deposition would be reduced 8 percent on average in the Eastern United States. The CAMR permits cap-and-trade approach that requires the nationwide emissions to meet the prescribed level, but do not require controls on each individual power plant. This has led to concerns that there may be hot-spots of mercury contamination near power plants. Partially because of this concern, many states including Pennsylvania have implemented, or are considering, state regulations that are stricter on mercury emissions than those in the CAMR. This study examined the possibility that coal-fired power plants act as local sources leading to mercury 'hot spots'. Soil and oak leaf samples from around three large U.S. coal-fired power plants in Western Pennsylvania were collected and analyzed for evidence of 'hot spots'. These three plants (Conemaugh, Homer City, and Keystone) are separated by a total distance of approximately 30 miles. Each emits over 500 pounds of mercury per year which is well above average for mercury emissions from coal plants in the U.S. Soil and oak leaf sampling programs were performed around each power plant. Sampling rings one-mile apart were used with eight or nine locations on each ring. The prevailing winds in the region are from the west. For this reason, sampling was conducted out to 10 miles from the Conemaugh plant which is southeast of the others. The other plants were sampled to a distance of five miles. The objectives were to determine if local mercury hot spots exist, to determine if they could be attributed to deposition of coal-fired power plant emissions, and to determine if they correlated with wind patterns. The study found the following: (1) There was some correlation between the prevailing wind direction and measured soil and oak leaf concentrations. This correlation was not statistically significant, but higher soil concentrations were generally found in the east and southeast from the plants and lower soil concentrations were found west/southwest from the plants. The prevailing winds are to the east. The Conemaugh plant which was the most southeast of the three plants did have the highest average oak leaf and soil mercury concentrations. Based on emissions, the Keystone plant would be expected to see the highest concentrations as it emitted about 25% more mercury than the other two plants. (2) The results of this study did not turn up strong evidence for large areas (several square miles) of elevated mercury concentrations around the three coal-fired power plants that were tested. This does not mean that there is no effect, there was some evidence of increasing mercury content to the east and south of these plants, however, the trends were not statistically significant suggesting that if the effects exist, they are small

A review of trisomy X (47,XXX)

Trisomy X is a sex chromosome anomaly with a variable phenotype caused by the presence of an extra X chromosome in females (47,XXX instead of 46,XX). It is the most common female chromosomal abnormality, occurring in approximately 1 in 1,000 female births. As some individuals are only mildly affected or asymptomatic, it is estimated that only 10% of individuals with trisomy X are actually diagnosed. The most common physical features include tall stature, epicanthal folds, hypotonia and clinodactyly. Seizures, renal and genitourinary abnormalities, and premature ovarian failure (POF) can also be associated findings. Children with trisomy X have higher rates of motor and speech delays, with an increased risk of cognitive deficits and learning disabilities in the school-age years. Psychological features including attention deficits, mood disorders (anxiety and depression), and other psychological disorders are also more common than in the general population. Trisomy X most commonly occurs as a result of nondisjunction during meiosis, although postzygotic nondisjunction occurs in approximately 20% of cases. The risk of trisomy X increases with advanced maternal age. The phenotype in trisomy X is hypothesized to result from overexpression of genes that escape X-inactivation, but genotype-phenotype relationships remain to be defined. Diagnosis during the prenatal period by amniocentesis or chorionic villi sampling is common. Indications for postnatal diagnoses most commonly include developmental delays or hypotonia, learning disabilities, emotional or behavioral difficulties, or POF. Differential diagnosis prior to definitive karyotype results includes fragile X, tetrasomy X, pentasomy X, and Turner syndrome mosaicism. Genetic counseling is recommended. Patients diagnosed in the prenatal period should be followed closely for developmental delays so that early intervention therapies can be implemented as needed. School-age children and adolescents benefit from a psychological evaluation with an emphasis on identifying and developing an intervention plan for problems in cognitive/academic skills, language, and/or social-emotional development. Adolescents and adult women presenting with late menarche, menstrual irregularities, or fertility problems should be evaluated for POF. Patients should be referred to support organizations to receive individual and family support. The prognosis is variable, depending on the severity of the manifestations and on the quality and timing of treatment

Unambiguous molecular detections with multiple genetic approach for the complicated chromosome 22q11 deletion syndrome

<p>Abstract</p> <p>Background</p> <p>Chromosome 22q11 deletion syndrome (22q11DS) causes a developmental disorder during the embryonic stage, usually because of hemizygous deletions. The clinical pictures of patients with 22q11DS vary because of polymorphisms: on average, approximately 93% of affected individuals have a de novo deletion of 22q11, and the rest have inherited the same deletion from a parent. Methods using multiple genetic markers are thus important for the accurate detection of these microdeletions.</p> <p>Methods</p> <p>We studied 12 babies suspected to carry 22q11DS and 18 age-matched healthy controls from unrelated Taiwanese families. We determined genomic variance using microarray-based comparative genomic hybridization (array-CGH), quantitative real-time polymerase chain reaction (qPCR) and multiplex ligation-dependent probe amplification (MLPA).</p> <p>Results</p> <p>Changes in genomic copy number were significantly associated with clinical manifestations for the classical criteria of 22q11DS using MPLA and qPCR (<it>p </it>< 0.01). An identical deletion was shown in three affected infants by MLPA. These reduced DNA dosages were also obtained partially using array-CGH and confirmed by qPCR but with some differences in deletion size.</p> <p>Conclusion</p> <p>Both MLPA and qPCR could produce a clearly defined range of deleted genomic DNA, whereas there must be a deleted genome that is not distinguishable using MLPA. These data demonstrate that such multiple genetic approaches are necessary for the unambiguous molecular detection of these types of complicated genomic syndromes.</p

A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma

BACKGROUND: Fractionated plasma metanephrine measurements are commonly used in biochemical testing in search of pheochromocytoma. METHODS: We aimed to critically appraise the diagnostic efficacy of fractionated plasma free metanephrine measurements in detecting pheochromocytoma. Nine electronic databases, meeting abstracts, and the Science Citation Index were searched and supplemented with previously unpublished data. Methodologic and reporting quality was independently assessed by two endocrinologists using a checklist developed by the Standards for Reporting of Diagnostic Studies Accuracy Group and data were independently abstracted. RESULTS: Limitations in methodologic quality were noted in all studies. In all subjects (including those with genetic predisposition): the sensitivities for detection of pheochromocytoma were 96%–100% (95% CI ranged from 82% to 100%), whereas the specificities were 85%–100% (95% CI ranged from 78% to 100%). Statistical heterogeneity was noted upon pooling positive likelihood ratios when those with predisposition to disease were included (p < 0.001). However, upon pooling the positive or negative likelihood ratios for patients with sporadic pheochromocytoma (n = 191) or those at risk for sporadic pheochromocytoma (n = 718), no statistical heterogeneity was noted (p = 0.4). For sporadic subjects, the pooled positive likelihood ratio was 5.77 (95% CI = 4.90, 6.81) and the pooled negative likelihood ratio was 0.02 (95% CI = 0.01, 0.07). CONCLUSION: Negative plasma fractionated free metanephrine measurements are effective in ruling out pheochromocytoma. However, a positive test result only moderately increases suspicion of disease, particularly when screening for sporadic pheochromocytoma